Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8231230rdf:typepubmed:Citationlld:pubmed
pubmed-article:8231230lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:8231230lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:8231230lifeskim:mentionsumls-concept:C0026985lld:lifeskim
pubmed-article:8231230lifeskim:mentionsumls-concept:C0012929lld:lifeskim
pubmed-article:8231230lifeskim:mentionsumls-concept:C0699748lld:lifeskim
pubmed-article:8231230lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:8231230pubmed:issue11lld:pubmed
pubmed-article:8231230pubmed:dateCreated1993-12-3lld:pubmed
pubmed-article:8231230pubmed:abstractTextThe onset of acute myeloid leukemia following ionizing radiation or alkylating agent exposure is antedated months to years by the development of 'preleukemia', or secondary myelodysplastic syndrome (sMDS). Mitochondrial abnormalities induced by chloramphenicol and clonal deletions of mitochondrial DNA (mt DNA) in the bone marrow create hematological defects similar to sMDS, and abnormal dimers of mt DNA are observed in acute leukemia. This suggests a role for mt DNA in the pathogenesis of sMDS and secondary leukemia. We outline disparate experimental evidence to support this concept and suggest a role for select protease inhibitors in the clinical management of this disorder.lld:pubmed
pubmed-article:8231230pubmed:languageenglld:pubmed
pubmed-article:8231230pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8231230pubmed:citationSubsetIMlld:pubmed
pubmed-article:8231230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8231230pubmed:statusMEDLINElld:pubmed
pubmed-article:8231230pubmed:monthNovlld:pubmed
pubmed-article:8231230pubmed:issn0145-2126lld:pubmed
pubmed-article:8231230pubmed:authorpubmed-author:KirbyRRlld:pubmed
pubmed-article:8231230pubmed:authorpubmed-author:HatfillS JSJlld:pubmed
pubmed-article:8231230pubmed:authorpubmed-author:DowningT GTGlld:pubmed
pubmed-article:8231230pubmed:authorpubmed-author:LaubscherRRlld:pubmed
pubmed-article:8231230pubmed:authorpubmed-author:La CockC JCJlld:pubmed
pubmed-article:8231230pubmed:issnTypePrintlld:pubmed
pubmed-article:8231230pubmed:volume17lld:pubmed
pubmed-article:8231230pubmed:ownerNLMlld:pubmed
pubmed-article:8231230pubmed:authorsCompleteYlld:pubmed
pubmed-article:8231230pubmed:pagination907-13lld:pubmed
pubmed-article:8231230pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:8231230pubmed:meshHeadingpubmed-meshheading:8231230-...lld:pubmed
pubmed-article:8231230pubmed:meshHeadingpubmed-meshheading:8231230-...lld:pubmed
pubmed-article:8231230pubmed:meshHeadingpubmed-meshheading:8231230-...lld:pubmed
pubmed-article:8231230pubmed:meshHeadingpubmed-meshheading:8231230-...lld:pubmed
pubmed-article:8231230pubmed:meshHeadingpubmed-meshheading:8231230-...lld:pubmed
pubmed-article:8231230pubmed:meshHeadingpubmed-meshheading:8231230-...lld:pubmed
pubmed-article:8231230pubmed:meshHeadingpubmed-meshheading:8231230-...lld:pubmed
pubmed-article:8231230pubmed:year1993lld:pubmed
pubmed-article:8231230pubmed:articleTitleA role for mitochondrial DNA in the pathogenesis of radiation-induced myelodysplasia and secondary leukemia.lld:pubmed
pubmed-article:8231230pubmed:affiliationDepartment of Hematological Pathology, University of Stellenbosch Medical School, Tygerberg Hospital, South Africa.lld:pubmed
pubmed-article:8231230pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8231230pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8231230lld:pubmed